Flamel Technologies SA is listed on the NASDAQ [FLML] and is a leading drug delivery company focused on the goal of developing safer, more efficacious formulations of drugs to tackle unmet medical needs. Their product development pipeline includes biological and chemical drugs formulated with their proprietary platforms, Medusa® and Micropump®.